Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
03/2010
03/31/2010EP2167484A2 Condensed anthranilamide insecticides
03/31/2010EP2167478A1 Benzoxazine containing compositions of matter and curable compositions made therewith
03/31/2010EP2167467A1 Method for producing dioxazine derivatives
03/31/2010EP2166854A1 Triazole derivatives for treating alzheimer's disease and related conditions
03/31/2010EP2166850A1 New heteocyclic h3 antagonists
03/31/2010EP2166846A1 Inhibitors of janus kinases
03/31/2010EP1904465B1 Method of synthesis of imidazole-amino acid derivatives and related compounds
03/31/2010EP1620091B1 Inhibitors of glutaminyl cyclase
03/31/2010EP1546107B1 Cox-2 inhibiting pyridine derivatives
03/31/2010EP1252139B1 Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides
03/31/2010CN101687862A Crystalline form of [3-(4,5-dihydro-3-isoxazolyl)-2-methyl-4-(methylsulfonyl)phenyl]-(5-hydroxy-1-methyl-1h-pyrazol-4-yl)methanone
03/31/2010CN101687861A Pyrazoles useful in the treatment of inflammation
03/31/2010CN101687860A Novel n- (8-heteroaryltetrahydronaphtalene-2yl) or n- (5- heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
03/31/2010CN101687857A Pyridazinone derivates
03/31/2010CN101687855A Phthalazinone derivatives and their use as medicament to treat cancer
03/31/2010CN101687841A Benzimidazole derivatives
03/31/2010CN101687821A protein kinase inhibitors and methods for using thereof
03/31/2010CN101687816A Triaminopyrimidine derivatives as inhibitors of cdc25 phosphatase
03/31/2010CN101687804A Method for producing dioxazine derivatives
03/31/2010CN101687797A Malonamide derivatives with antithrombotic activity
03/31/2010CN101687786A Hydroxylamine compounds and methods of their use
03/31/2010CN101684095A Novel organic electroluminescent compounds and organic electroluminescent device using the same
03/31/2010CN101684091A cannabinoid receptor ligands
03/30/2010US7687643 For angiogenesis mediated diseases; cancer; acylation, cyclization and Heck-type reduction
03/30/2010US7687640 3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzaldehyde; inhibits production of A beta 40 and A beta 42 from amyloid precursor protein ; Alzheimer's disease and Down syndrome
03/30/2010US7687627 Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
03/30/2010US7687535 Substituted 3-sulfur indoles
03/30/2010US7687533 N-(1-arylpyrazol-4l) sulfonamides and their use as parasiticides
03/30/2010US7687532 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of I.A. rheumatoid arthritis
03/30/2010US7687525 e.g. N-(2-aminophenyl)-4-(N-benzoylaminomethyl)benzamide hydrochloride; anticarcinogenic, antitumor agents; hematologic malignancy and a solid carcinoma; autoimmune disease, skin disorders;
03/30/2010US7687510 Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes
03/30/2010US7687509 N-(2-(4-(4-fluoro(benzyl-d6)carbamoyl)-5-hydroxy-1-(methyl-d3)-6-oxo-1,6-dihydropyrimidin-2-yl)-(1,3-d6-propan)-2-yl)-5-(methyl-d3)-1,3,4-oxadiazole-2-carboxamide; use in methods of treating HIV infections
03/30/2010US7687508 Cyclic derivatives as modulators of chemokine receptor activity
03/30/2010US7687503 2-(methylamino)-2-oxoethyl 4-{5-[3-(trifluoromethyl)-phenyl]-2-pyridyl}-1-piperazinecarboxylate, for example; enzyme inhibitors of fatty acid amide hydrolases; treatment of pain, eating disorders, neurological and psychiatric pathologies, among other disorders
03/30/2010US7687502 Substituted quinazoline or pyridopyrimidine derivative
03/30/2010US7687499 (4-cyclopropyl-piperazin-1-yl)-(4-morpholin-4-ylmethyl-phenyl)-methanone, and (4-cyclopropyl-piperazin-1-yl)-[4-(2-hydroxymethyl-morpholin-4-ylmethyl)-phenyl]-methanone, for example; treatment of a variety of CNS related disorders including narcolepsy, sleep disorders, obesity
03/30/2010US7687498 N-(Arylidene)morpholinylpyridinylhydrazine derivatives, e.g., N-{4-[2-(3,4-Dimethoxy-phenyl)-ethoxy]-6-morpholin-4-yl-pyridin-2-yl}-N'-(3-methyl-benzylidene)-hydrazine, are used for treating interleukin-12 overproduction-related disorders including inflammatory diseases
03/30/2010US7687492 1,2,4-Oxadiazole derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
03/30/2010US7687491 Immunosuppressants with low toxicity; 1-({4-Methyl-5-[5-(4-phenoxyphenyl)-1,2,4-oxadiazol-3-yl]-2-thienyl}methyl)azetidine-3-carboxylic acid for example; autoimmune diseases and transplant rejection; N-substituted azetidine, pyrrolidine or piperidine compounds
03/30/2010CA2572508C One pot synthesis of 2-oxazolidinone derivatives
03/30/2010CA2564990C Morpholine compounds
03/30/2010CA2445395C Heterocyclic compound and antitumor agent comprising the same as effective component
03/30/2010CA2405971C New piperazine and piperidine compounds
03/30/2010CA2389306C Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
03/25/2010WO2010033543A2 Novel compounds as cannabinoid receptor ligands
03/25/2010WO2010033481A1 Salts of n-[6-cis-2,6-dimethylmorpholin-4yl)pyridine-3yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide
03/25/2010WO2010033168A2 Amide compounds, compositions and uses thereof
03/25/2010WO2010032874A1 Composition for agricultural use
03/25/2010WO2010032856A1 Nitrogen-containing heterocyclic compound and use of same
03/25/2010WO2010032437A1 Nitrogen-containing heterocyclic compound and pest control agent
03/25/2010WO2010031852A1 Novel estrogen receptor ligands
03/25/2010WO2010031735A1 Piperazine d3 and 5-ht2a receptor modulators
03/25/2010WO2010031713A1 Substituted pyrrolidine-2-carboxamides
03/25/2010WO2010031708A2 Novel ortho-aminoanilides for the treatment of cancer
03/25/2010WO2010031497A1 New process for the preparation of iloperidone
03/25/2010WO2010008733A3 Solid forms of (1r,2s,3r)-1-(2-(isoxazol-3-yl)-1h-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use
03/25/2010WO2009146540A8 N-piperidinyl acetamide derivatives as calcium channel blockers
03/25/2010US20100076186 Process for preparing heterocycles
03/25/2010US20100076051 Isoindolinone kinase inhibitors
03/25/2010US20100076040 Method For Producing Bisbenzoxazoles
03/25/2010US20100075985 Benzo[d]isoxazol-3-yl-piperazin derivatives useful as modulators of dopamine d3 receptors
03/25/2010US20100075984 Dicarbonylic compounds with antibacterial activity
03/25/2010US20100075983 D3 and 5-ht2a receptor modulators
03/25/2010US20100075974 Heterocyclic gpr40 modulators
03/25/2010US20100075971 Substituted pyridine derivatives useful in the treatment of cancer and other disorders
03/25/2010US20100075970 Inhibitors of akt activity
03/25/2010US20100075968 Imidazolidine Carboxamide Derivatives as P2X7 Modulators
03/25/2010US20100075967 Pyrimidine derivatives for treatment of hyperproliferative disorders
03/25/2010US20100075966 Substituted Dihydroimidazoles and their Use in the Treatment of Tumors
03/25/2010US20100075965 Pi3 kinase inhibitors and methods of their use
03/25/2010US20100075964 Imidazole based lxr modulators
03/25/2010US20100075963 Pharmaceutically Active Benzensulphonyl-Indols
03/25/2010US20100075962 Indol derivatives, the method for preparing thereof and composition for the prevention and treatment of metabolic disorder containing the same as an active ingredient
03/25/2010US20100075961 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
03/25/2010US20100075960 Benzimidazole thiophene compounds
03/25/2010US20100075956 N-(1-arylpyrazol-4l)sulfonamides and their use as parasiticides
03/25/2010US20100075951 Heteroaryls and uses thereof
03/25/2010US20100075949 Novel pyrrolidin-2-ones
03/25/2010US20100075948 Substituted Pyrrolidine-2-Carboxamides
03/25/2010US20100075944 Novel pyridine derivatives and pyrimidine derivatives (3)
03/25/2010US20100075931 Substituted oxazole ketone modulators of fatty acid amide hydrolase
03/25/2010US20100075348 Method for diagnosis of a disease involving an anti-endothelin-receptor antibody
03/25/2010CA2737291A1 Nitrogen-containing heterocyclic compound and pest control agent
03/25/2010CA2737199A1 Novel compounds as cannabinoid receptor ligands
03/25/2010CA2737038A1 Amide compounds, compositions and uses thereof
03/25/2010CA2734363A1 Substituted pyrrolidine-2-carboxamides
03/25/2010CA2734349A1 Novel ortho-aminoanilides for the treatment of cancer
03/24/2010EP2165708A2 New pyrazole derivatives as transforming growth factor (tgf) inhibitors
03/24/2010EP2164844A1 Pyrimidinyl pyridazinone derivates
03/24/2010EP2164843A1 Pyridazinone derivates
03/24/2010EP2164326A1 Amide compounds and the use thereof
03/24/2010EP1789404B1 Substituted n-arylsulfonylheterocyclic amines as gamma-secretase inhibitors
03/24/2010EP1644357B9 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
03/24/2010EP1615699B1 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
03/24/2010EP1389110B1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
03/24/2010CN101679403A Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators 842
03/24/2010CN101679402A Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators 841
03/24/2010CN101679401A 2-oxo-3-benzyl-benzoxazol-2-one derivatives and related compounds as MET kinase inhibitors for the treatment of tumors
03/24/2010CN101679400A Novel carbamoyloxy aryl alkan arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
03/24/2010CN101679399A Novel carbamoyloxy arylalkanoyl arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
1 ... 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 ... 647